Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Target-Date · J.P. Morgan

JPMorgan SmartRetirement 2065 Fund Class R3 (JSMPX)

Ticker JSMPX · · Holdings as of Jun 30, 2026

Expense ratio
0.89%$89/yr per $10k
1-yr return
+17.5%as of Dec 2025
Net assets
$176.8Mall share classes
Holdings
24

Bottom line

Is JSMPX a good fund? The bottom line

JSMPX is the Class R3 share class of JPMorgan SmartRetirement 2065 Fund, an actively managed target-date mutual fund from J.P. Morgan.

It charges 0.89% — about $89 a year on every $10,000 invested, more expensive than 77% of target-date funds we track.

It returned +17.5% over one year (as of Dec 31, 2025, per its prospectus).

With $177 million in net assets and 24 holdings, its largest position is JPMorgan International Research Enhanced Equity ETF (13.4%) and the top 10 make up 87.3% of the portfolio.

What to watch

  • Expensive for its category (0.89%)
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What JSMPX invests in

The Fund seeks high total return with a shift to current income and some capital appreciation over time as the Fund approaches and passes the target retirement date.

The JPMorgan SmartRetirement 2065 Fund is generally intended for investors who plan to retire around the year 2065 (the target retirement year). Prior to reaching the target retirement year, the Fund seeks risk appropriate total return with a shift to current income and some capital appreciation over time as the Fund approaches and passes the target retirement year. The Fund assumes a person will be at or around age 65 at the target retirement year. The Fund is designed to provide exposure to equity, fixed income and cash/cash equivalent asset classes by investing in mutual funds and exchange traded funds (ETFs) within the same group of investment companies (i.e., J.P. Morgan Funds), passive ETFs that are managed by unaffiliated investment advisers in certain limited instances (unaffiliated passive ETFs) (collectively with the J.P. Morgan Funds, the underlying funds) and/or direct…

From the fund's prospectus (filed Oct 27, 2026).

JSMPX performance

Average annual total returns
1 yr5 yr10 yr
JSMPX+17.5%——
Target-Date median+15.7%+8.2%+8.9%

Source: Fund prospectus, as of Dec 31, 2025

Full JSMPX performance history →

What JSMPX costs

On a $10,000 investment, JSMPX's 0.89% expense ratio costs about $89 a year. The prospectus estimates $1,573 in total costs over 10 years (assuming 5% annual returns). The median target-date fund charges 0.59%.

See the full JSMPX fee table →

JSMPX top 10 holdings

#Holding% of fund
1JPMorgan International Research Enhanced Equity ETF13.36%
2JPMorgan U.S. Research Enhanced Equity Fund11.59%
3JPMorgan U.S. Equity Fund11.45%
4JPMorgan Value Advantage Fund11.31%
5JPMorgan Growth Advantage Fund11.00%
6JPMorgan Global Select Equity ETF9.08%
7JPMorgan International Equity Fund7.09%
8JPMorgan Core Plus Bond Fund4.60%
9JPMorgan BetaBuilders U.S. Mid Cap Equity ETF4.16%
10JPMorgan ActiveBuilders Emerging Markets Equity ETF3.64%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 87.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to JSMPX

More funds like JSMPX →

JSMPX FAQ

What is the expense ratio of JSMPX?
JSMPX's expense ratio is 0.89%, which works out to about $89 a year for every $10,000 invested. The prospectus estimates total costs of $1,573 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is JSMPX a good investment?
It depends on your goals, but the data points to: expensive for its category (0.89%); 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does JSMPX hold?
JSMPX's largest holdings are JPMorgan International Research Enhanced Equity ETF (13.4%), JPMorgan U.S. Research Enhanced Equity Fund (11.6%), JPMorgan U.S. Equity Fund (11.4%), JPMorgan Value Advantage Fund (11.3%), JPMorgan Growth Advantage Fund (11.0%). It holds 24 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages JSMPX?
JSMPX is offered by J.P. Morgan through Jpmorgan Trust IV.